Welcome to our dedicated page for TRULIEVE CANNABIS news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on TRULIEVE CANNABIS stock.
Trulieve is a leading cannabis company with a focus on providing relief to patients through trusted products. Hand-grown plants in a natural environment ensure quality and purity at every step. Trulieve is a vertically integrated, multi-state operator with a strong market presence in Arizona, Florida, and Pennsylvania. The company's innovative products, high-quality brands, and commitment to customer experience make it a top choice for those seeking access to cannabis products.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced an expanded partnership with Connected Cannabis Co. to exclusively produce, process, and retail Connected-branded products across Florida. This partnership will enhance Trulieve's offering of premium cannabis strains, already available in Arizona. Products will arrive at Trulieve’s 111 Florida dispensaries later this year. Trulieve, a leading medical cannabis provider in Florida, aims to benefit patients with a wider selection of high-quality products.
Trulieve Cannabis Corp. has launched Live Diamonds by Muse™, a new cannabis concentrate made with hydrocarbon extraction, marking a first for Florida. The initial release of 500 units sold out within 24 hours, with a new batch expected in February 2022. Retailing at $45 for 0.5 grams, the launch strain, White Fire Alien, is noted for its natural flavors. Trulieve emphasizes its commitment to high-quality products, hoping to expand patient access while delivering innovative cannabis solutions.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced the opening of its 160th dispensary in the U.S., located at 1222 Arch St. in Philadelphia. This new establishment, managed by Chamounix Ventures, LLC, offers a range of medical marijuana products including whole flower, vapes, and tinctures. The dispensary is part of Trulieve's commitment to serving Pennsylvania's patient community and will operate Monday to Saturday from 9 AM to 8 PM, and Sundays from 10 AM to 6 PM. Trulieve currently has multiple dispensaries across Pennsylvania, enhancing its market presence.
El Blunto, California's leading blunt producer, is expanding into Arizona through a partnership with Trulieve Cannabis Corp. Starting January 7, 2022, El Blunto products will be exclusively available at all Trulieve-affiliated Harvest retail locations in Arizona for two weeks. This move marks a significant national expansion for El Blunto, known for high-quality cannabis pre-rolls. CEO Q. Ladraa expressed excitement about the collaboration, highlighting Trulieve's approach to customer satisfaction. El Blunto's products will now reach consumers in over 400 dispensaries across California and Arizona.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced its participation in upcoming investor conferences in January 2022. Key events include the ICR Conference on January 10, where CEO Kim Rivers will engage in a fireside chat, followed by the ATB Capital Markets conference on January 13 with President Steve White participating in a panel discussion. Finally, CEO Kim Rivers will also speak at the Needham Growth Conference on January 14. Operating in 11 states, Trulieve is recognized for its innovative products and customer-focused approach.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announces the acquisition of PurpleMed Healing Center in Tucson, Arizona. The dispensary will be rebranded as Harvest House of Cannabis and is set to reopen on Dec. 29, 2021. This location becomes Trulieve's 17th dispensary in Arizona, targeting both medical and recreational customers. The acquisition is deemed immaterial in financial terms, with limited initial operating hours. This expansion reflects Trulieve's strategy to increase its market presence in Arizona, particularly in Tucson, the state's second-largest market.
Trulieve Cannabis Corp. is set to open its 112th dispensary in Florida, located in Port Richey, on December 23. This marks a significant expansion for the leading U.S. cannabis provider, offering a 25% discount for registered patients on opening day. The new location will provide personalized patient care and a wide selection of THC and CBD products. Trulieve emphasizes its commitment to patient accessibility and quality service. The grand opening will feature various promotional activities, including local business partnerships and customer giveaways.
Trulieve Cannabis Corp. has opened its eighth medical cannabis dispensary in the Tampa area, enhancing patient access in Florida. Located at 7702 E. Hillsborough Avenue, the new dispensary offers a 25% discount for registered patients on opening day, alongside special offers on various products. As part of the ongoing 12 Days of Cannabis promotion, new chocolate edibles will also debut. Trulieve, a leading cannabis provider in the U.S., continues to expand its reach and product offerings, aiming to deliver high-quality patient care and a range of THC and CBD options.
Trulieve Cannabis Corp. has opened its 111th dispensary in Florida, located in Okeechobee. The grand opening is set for December 9, 2021, and will feature a 25% discount for registered patients and a 50% discount for first-time customers. The new dispensary offers a wide selection of THC and CBD products, including brands exclusive to Trulieve. As the leading medical cannabis provider in Florida, Trulieve remains committed to enhancing patient care and expanding its retail presence, having opened over 40 dispensaries in the state this year.
FAQ
What is the current stock price of TRULIEVE CANNABIS (TCNNF)?
What is the market cap of TRULIEVE CANNABIS (TCNNF)?
What is Trulieve's core focus?
Where does Trulieve operate?
What sets Trulieve apart from other cannabis companies?
How does Trulieve ensure product quality?